10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
BRISTOL MYERS SQUIBB CO | |||
Ticker: BMY Fiscal Year: 2020 | |||
CONSOLIDATED STATEMENTS OF EARNINGS | |||
Period Ending Dec 31, 2020 10-K (Filed: Feb 10, 2021) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | |
| Revenues | $ 42,518 | 26,145 | 22,561 |
| Cost of products sold | 11,773 [1] | 8,078 | 6,467 |
| Marketing, selling and administrative | 7,661 | 4,871 | 4,551 |
| Research and development | 11,143 | 6,148 | 6,332 |
| MyoKardia Asset Acquisition IPRD Charge | 11,438 | 0 | 0 |
| Amortization of Acquired Intangible Assets | 9,688 | 1,135 | 97 |
| Other (income)/expense, net | (2,314) | 938 | (854) |
| Total Expenses | 49,389 | 21,170 | 16,593 |
| (Loss)/Earnings Before Income Taxes | (6,871) | 4,975 | 5,968 |
| Provision for Income Taxes | 2,124 | 1,515 | 1,021 |
| Net (Loss)/Earnings | (8,995) | 3,460 | 4,947 |
| Noncontrolling Interest | 20 | 21 | 27 |
| Net (Loss)/Earnings Attributable to BMS | (9,015) | 3,439 | 4,920 |
| Basic Earnings Per Common Share Attributable to BMS | (3.99) | 2.02 | 3.01 |
| Diluted Earnings per Common Share Attributable to BMS | (3.99) | 2.01 | 3.01 |
| Principal Transaction Revenue, Description of Reporting Category | |||
| Net product sales | |||
| Revenues | 41,321 | 25,174 | 21,581 |
| Alliance and other revenues | |||
| Revenues | 1,197 | 971 | 980 |
| [1] Excludes amortization of acquired intangible assets. | |||
| External Links | |
| BRISTOL MYERS SQUIBB CO (BMY) Fiscal Year 2020 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |